Clinical Trial Update: ADDIA Chronobiological Study

View source ↗

Summary

The ADDIA chronobiological study sponsored by Amoneta Diagnostics SAS, investigating Alzheimer's disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Amoneta Diagnostics SAS | Conditions: Alzheimer Disease | Status: COMPLETED